 |
 |

PLASMA LIPIDS IN PRIMARY (XANTHOMATOSIS) AND SECONDARY HYPERCHOLESTEREMIAI. The Effect of Lipotropic Substances
ALLEN F. DELEVETT, M. D.;
MAURICE BRUGER, M. D.
Arch Intern Med. 1948;81(6):859-867.
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
 |
 |
HYPERCHOLESTEREMIA is a common observation in some well recognized metabolic disorders. The elevated level of cholesterol in the serum may represent a primary defect in the metabolism of this sterol (xanthomatosis )1 or may signify a derangement in lipid metabolism secondary to some underlying metabolic disturbance, such as diabetes mellitus, hypothyroidism and nephrosis. The present study embraces both types of hypercholesteremia. The first part of the investigation is concerned with the effect of several lipotropic substances on the plasma lipids and the second, which will be reported later, with diets low in cholesterol values.
MATERIAL AND METHODS
Thirteen patients were studied. The disease in 9 of these was classified as primary (essential) xanthomatosis with hypercholesteremia2 and in 4 as secondary hypercholesteremia due to various metabolic disorders. The clinical data on these patients are detailed in table I.
The following lipotropic materials3 were used (oral route): (a) vitamin E,
. . . [Full Text PDF of this Article]
Author Affiliations
Research Assistant in Medicine; NEW YORK
From the Division of Cardiology and the Medical Research Laboratory, Department of Medicine, New York Post-Graduate Medical School and Hospital, New York.
Footnotes
Aided by a grant from the New York Diabetes Association.
|